Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Recent evidence from the STEP-HFpEF and STEP-HFpEF-DM trials provides the first robust data supporting the efficacy of GLP-1 RAs, specifically semaglutide, in improving the quality of life in obese patients with HFpEF
P.RuizL.FolgueiraC.RadaP.Gomez-SantosB.SolasM.et al (2024)
:max_bytes(150000):strip_icc()/VWH-GettyImages-2196287905-42e440cc5f714dfb8793161a905904d9.jpg)
Contraindications are similar to metformin: avoid with renal failure or severe liver disease
What are Semaglutide GLP-1, Mounjaro, Wegovy and Ozempic approved for
US$ 22.12
US$ 23.80
US$ 27.93
US$ 27.77
US$ 20.65
US$ 26.65
US$ 27.76
